{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:52:53Z","timestamp":1648709573131},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.canlet.2010.10.007","type":"journal-article","created":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T08:16:43Z","timestamp":1288513003000},"page":"205-214","source":"Crossref","is-referenced-by-count":8,"title":["Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr\u2013Abl mutant by a redox-mediated mechanism"],"prefix":"10.1016","volume":"300","author":[{"given":"Chiara","family":"Corrado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Raimondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Flugy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Stassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Marfia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Iovino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Arlinghaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise C.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo De","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Alessandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2010.10.007_b0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.10.007_b0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.10.007_b0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.189.8.1229","article-title":"Signal transducer and activator of transcription (STAT)5 activation by BCR\/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR\/ABL and is required for leukemogenesis","volume":"189","author":"Nieborowska-Skorska","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2010.10.007_b0020","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V95.6.2118","article-title":"STAT5 activation contributes to growth and viability in Bcr\/Abl-transformed cells","volume":"95","author":"Sillaber","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.10.007_b0025","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1074\/jbc.M111501200","article-title":"Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR\/ABL in K562 cells","volume":"277","author":"Sonoyama","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2010.10.007_b0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/107327480901600202","article-title":"Signaling networks associated with BCR\u2013ABL-dependent transformation","volume":"16","author":"Hazlehurst","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.canlet.2010.10.007_b0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr\u2013Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2010.10.007_b0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood-2002-02-0545","article-title":"Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses","volume":"101","author":"Kantarjian","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.10.007_b0045","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.biocel.2007.10.001","article-title":"Overcoming kinase resistance in chronic myeloid leukemia","volume":"40","author":"Lee","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2010.10.007_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR\u2013ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cells"},{"key":"10.1016\/j.canlet.2010.10.007_b0055","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1200\/JCO.2008.19.8853","article-title":"Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR\/ABL mutants","volume":"27","author":"Redaelli","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2010.10.007_b0060","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1073\/pnas.0504952102","article-title":"Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases","volume":"102","author":"Carter","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.10.007_b0065","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/leu.2008.74","article-title":"Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism","volume":"22","author":"Zhang","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2010.10.007_b0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr\u2013Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.10.007_b0075","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1200\/JCO.2003.04.136","article-title":"Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer","volume":"21","author":"Hussain","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2010.10.007_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jcp.21290","article-title":"Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia","volume":"215","author":"Alessandro","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2010.10.007_b0085","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI200318174","article-title":"Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling","volume":"111","author":"Nathan","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2010.10.007_b0090","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1124\/mol.106.024323","article-title":"Inhibition of Ca2+ influx is required for mitochondrial reactive oxygen species-induced endoplasmic reticulum Ca2+ depletion and cell death in leukemia cells","volume":"70","author":"Zhang","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2010.10.007_b0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2010.10.007_b0100","doi-asserted-by":"crossref","first-page":"13468","DOI":"10.1074\/jbc.M610616200","article-title":"Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress","volume":"282","author":"Feng","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2010.10.007_b0105","doi-asserted-by":"crossref","first-page":"30151","DOI":"10.1074\/jbc.M802529200","article-title":"Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells","volume":"283","author":"Xiao","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2010.10.007_b0110","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s10495-008-0278-6","article-title":"In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway","volume":"13","author":"Zhang","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.canlet.2010.10.007_b0115","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1158\/0008-5472.CAN-08-1054","article-title":"Bobel-24 and derivatives induce caspase-independent death in pancreatic cancer regardless of apoptotic resistance","volume":"68","author":"Parreno","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.007_b0120","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/1535-7163.MCT-05-0257","article-title":"Novel triiodophenol derivatives induce caspase independent mitochondrial cell death in leukemia cells inhibited by Myc","volume":"5","author":"Parreno","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2010.10.007_b0125","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1021\/pr0704128","article-title":"Comparative proteome profiling and functional analysis of chronic myelogenous leukemia cell lines","volume":"6","author":"Fontana","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.canlet.2010.10.007_b0130","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL","volume":"354","author":"Kantarjian","year":"2006","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.10.007_b0135","doi-asserted-by":"crossref","first-page":"11314","DOI":"10.1158\/0008-5472.CAN-06-1199","article-title":"In vitro and in vivo activity of SKI-606, a novel Src\u2013Abl inhibitor, against imatinib-resistant Bcr\u2013Abl+ neoplastic cells","volume":"66","author":"Puttini","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.007_b0140","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-05-0259","article-title":"In vitro activity of Bcr\u2013Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants","volume":"65","author":"O\u2019Hare","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.007_b0145","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/blood-2006-07-035493","article-title":"Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure","volume":"109","author":"Quintas-Cardama","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.10.007_b0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(02)07679-1","article-title":"BCR\u2013ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study","volume":"359","author":"von Bubnoff","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2010.10.007_b0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/theoncologist.2007-0170","article-title":"Therapy options in imatinib failures","volume":"13","author":"Ramirez","year":"2008","journal-title":"The Oncologist"},{"key":"10.1016\/j.canlet.2010.10.007_b0160","doi-asserted-by":"crossref","first-page":"39485","DOI":"10.1074\/jbc.M503296200","article-title":"Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress","volume":"280","author":"Hu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2010.10.007_b0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature03688","article-title":"Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability","volume":"436","author":"Radisky","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.10.007_b0170","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1126\/science.275.5306.1649","article-title":"Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts","volume":"275","author":"Irani","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.10.007_b0175","doi-asserted-by":"crossref","first-page":"24273","DOI":"10.1074\/jbc.M002094200","article-title":"The BCR\/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells","volume":"275","author":"Sattler","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2010.10.007_b0180","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S1097-2765(02)00520-8","article-title":"c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability","volume":"9","author":"Vafa","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2010.10.007_b0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.canlet.2010.10.007_b0190","doi-asserted-by":"crossref","first-page":"37832","DOI":"10.1074\/jbc.M301546200","article-title":"Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism","volume":"278","author":"Pelicano","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2010.10.007_b0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","article-title":"BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance","volume":"108","author":"Koptyra","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.10.007_b0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2006.08.009","article-title":"Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate","volume":"10","author":"Trachootham","year":"2006","journal-title":"Cancer Cells"},{"key":"10.1016\/j.canlet.2010.10.007_b0205","first-page":"4379","article-title":"Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3","volume":"26","author":"Su","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2010.10.007_b0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jcp.22140","article-title":"Dysregulated calcium homeostasis and oxidative stress in chronic Myeloid leukemia (CML) cells","volume":"224","author":"Ciarcia","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2010.10.007_b0215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tips.2004.03.005","article-title":"Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling","volume":"25","author":"Hong","year":"2004","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383510004830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383510004830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T11:47:36Z","timestamp":1592048856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383510004830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0304383510004830"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2010.10.007","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}